Search
Filter Results
Displaying 71–80 of 653 for “retinal diseases”
-
Funded Foundation Fighting Blindness Grants and Awards for Fiscal Year 2024 (July 1, 2023 – June 30, 2024)
-
The Foundation Fighting Blindness, the world’s leading private funding source for retinal degenerative disease research, will host online continuing medical education (CME and COPE) courses throughout the year. The continuing education courses will review a number of topics related to care and management of patients with inherited retinal diseases.
-
Sep 11, 2024
Recording Available: Foundation Insights Forum – August 29, 2024
Foundation NewsThe Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the blinding diseases community. The call took place on August 29, 2024.
-
Sep 27, 2021
Foundation Awarded 21 New Grants in FY2021 Totaling More than $14.2 Million
Research NewsCurrent research portfolio is comprised of nearly 100 projects at prominent institutions around the world
-
Funded Foundation Fighting Blindness Grants and Awards for Fiscal Year 2023 (July 1, 2022–June 30, 2023)
-
The Foundation Fighting Blindness, the world’s leading organization committed to finding treatments and cures for blinding retinal diseases, is hosts webinars to inform eye care professionals about the many opportunities to greatly enhance the quality of life, and provide hope, for their retinal disease patients.
-
Aug 16, 2019
Foundation Fighting Blindness Investing Nearly $6.5 Million in New Grants
Foundation NewsThe newly funded research efforts include several therapies that have strong potential to treat a wide range of inherited retinal diseases.
-
Scientific Grants and Awards Programs
The Grants and Awards Programs of the Foundation Fighting Blindness support basic, laboratory-based early translational, clinical studies and pre-clinical research applicable to a broad range of retinal degenerative diseases.
-
-
Nov 14, 2024
Research NewsStrengthening research in retinal disease with record-breaking $19.8 million investment in innovative projects targeting vision loss worldwide.